A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are pleased to have reached a ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

23andMe will continue to offer customers its DNA testing services after being bought out of bankruptcy by Regeneroon for $256 million. Your spit samples are changing hands. Skip to main content ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies. Latest U.S.

DNA testing company 23andMe is being purchased out of bankruptcy by large-cap drugmaker Regeneron for $256 million.The deal includes "substantially all assets" but excludes the telehealth platform ...

The biotech said it would buy 23andMe out of bankruptcy, potentially bringing to a close the saga of the genetic testing company. Skip to Main Content. Manage alerts for this article; ...

23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company that has used DNA ...

Regeneron says that 23andMe required any bidders to “guarantee” that they would comply with its existing privacy policies. A third-party consumer privacy ombudsman, or CPO, will be appointed ...

Americans curious about their ancestry likely paid for a DNA test through 23andMe. 23andMe is on the brink of a financial collapse. The company – founded in 2006 – is now considered ...